Forschungsartikel
A Double-Blind Randomized, Placebo-Controlled Phase 2 Clinical Trial to Evaluate Safety and Efficacy of US APR 2020 in Subjects with Chronic Kidney Disease Stage IV
Emmanuel Anteyi*, Pari Ranganathan, Usha Vyas, Qiannan Zhao, Nataraja Ranganathan